Sangamo Therapeutics Inc (SGMO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Sales | 25,800 | 57,763 | 21,553 | 13,076 | 54,851 |
| Gross Profit | 25,800 | 57,763 | 21,553 | 13,076 | 54,851 |
| Operating Expenses | 69,232 | 61,464 | 59,450 | 57,598 | 53,382 |
| Operating Income | -43,432 | -3,701 | -37,897 | -44,522 | 1,469 |
| Other Income | 2,865 | 2,430 | 1,932 | 1,548 | 3,032 |
| Pre-tax Income | -40,567 | -1,271 | -35,965 | -42,974 | 4,501 |
| Income Tax | 108 | 237 | 0 | 0 | N/A |
| Net Income Continuous | -40,675 | -1,508 | -35,965 | -42,974 | 4,501 |
| Minority Interests | -71 | 42 | -36 | -61 | -54 |
| Net Income | $-40,604 | $-1,550 | $-35,929 | $-42,913 | $4,555 |
| EPS Basic Total Ops | -0.26 | -0.01 | -0.26 | -0.37 | 0.06 |
| EPS Basic Continuous Ops | -0.26 | -0.01 | -0.26 | -0.37 | 0.06 |
| EPS Diluted Total Ops | -0.26 | -0.01 | -0.26 | -0.37 | 0.06 |
| EPS Diluted Continuous Ops | -0.26 | -0.01 | -0.26 | -0.37 | 0.06 |
| EBITDA(a) | $-39,249 | $-621 | $-35,069 | $-42,069 | $3,545 |